FDA approves Lilly, Incyte drug for alopecia, but includes safety warning
Bio Pharma Dive
JUNE 14, 2022
The partners’ JAK inhibitor Olumiant is the first systemic treatment for an autoimmune disease that causes hair loss. But known risks of heart attacks and cancer could complicate its launch.
Let's personalize your content